Table 1.
Selected Angiogenic Factors in Patients With Essential Thrombocythemia in Comparison to the Control Group.
| Parameter, Unit | Study Group (n = 60) | Control Group (n = 20) | P Value | ||
|---|---|---|---|---|---|
| Me/X | Q1;Q3/±SD | Me/X | Q1;Q3/±SD | ||
| Age, years | 61 | ±16.55 | 47 | ±9.21 | .003713 |
| VEGF-A, pg/mL | 104.65 | 52.24; 208.63 | 26.9 | 25.2; 27.5 | .000003 |
| sVEGFR-1, pg/mL | 100.67 | 74.56; 130.90 | 115.90 | 71.30; 156.00 | 0.697316 |
| sVEGFR-2, pg/mL | 8240.99 | ±2249.10 | 10693.09 | ±1716.49 | .000028 |
| PDGF-BB, pg/mL | 321.6 | 148.7; 841.3 | 178.90 | 90.91; 319.29 | .032830 |
| SDF-1α, pg/mL | 2122.1 | 1766.2; 2437.7 | 1890.00 | 1626.17; 3063.05 | 0.506417 |
Note. statistically significant values are in bold
Abbreviation: SD, standard deviation.